178 related articles for article (PubMed ID: 32133187)
1. Are low and middle-income countries prioritising high-value healthcare interventions?
Leech AA; Kim DD; Cohen JT; Neumann PJ
BMJ Glob Health; 2020; 5(2):e001850. PubMed ID: 32133187
[TBL] [Abstract][Full Text] [Related]
2. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Prevention of violence against women and girls: A cost-effectiveness study across 6 low- and middle-income countries.
Ferrari G; Torres-Rueda S; Chirwa E; Gibbs A; Orangi S; Barasa E; Tawiah T; Dwommoh Prah RK; Hitimana R; Daviaud E; Kapapa E; Dunkle K; Heise L; Stern E; Chatterji S; Omondi B; Ogum Alangea D; Karmaliani R; Maqbool Ahmed Khuwaja H; Jewkes R; Watts C; Vassall A
PLoS Med; 2022 Mar; 19(3):e1003827. PubMed ID: 35324910
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of malaria control in sub-Saharan Africa.
Goodman CA; Coleman PG; Mills AJ
Lancet; 1999 Jul; 354(9176):378-85. PubMed ID: 10437867
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis.
Rosettie KL; Joffe JN; Sparks GW; Aravkin A; Chen S; Compton K; Ewald SB; Mathew EB; Michael D; Pedroza Velandia P; Miller-Petrie MB; Stafford L; Zheng P; Weaver MR; Murray CJL
PLoS One; 2021; 16(12):e0260808. PubMed ID: 34928971
[TBL] [Abstract][Full Text] [Related]
8. Noncommunicable Disease (NCD) strategic plans in low- and lower-middle income Sub-Saharan Africa: framing and policy response.
Boudreaux C; Noble C; Coates MM; Kelley J; Abanda M; Kintu A; McLaughlin A; Marx A; Bukhman G
Glob Health Action; 2020 Dec; 13(1):1805165. PubMed ID: 32873212
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Interventions to Improve Maternal, Newborn and Child Health Outcomes: A WHO-CHOICE Analysis for Eastern Sub-Saharan Africa and South-East Asia.
Stenberg K; Watts R; Bertram MY; Engesveen K; Maliqi B; Say L; Hutubessy R
Int J Health Policy Manag; 2021 Nov; 10(11):706-723. PubMed ID: 33904699
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of strategies to combat cardiovascular disease, diabetes, and tobacco use in sub-Saharan Africa and South East Asia: mathematical modelling study.
Ortegón M; Lim S; Chisholm D; Mendis S
BMJ; 2012 Mar; 344():e607. PubMed ID: 22389337
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality.
Pace LE; Shulman LN
Oncologist; 2016 Jun; 21(6):739-44. PubMed ID: 27091419
[TBL] [Abstract][Full Text] [Related]
13. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of interventions to improve diagnosis and preventive therapy for paediatric tuberculosis in 9 sub-Saharan African countries: A modelling study.
Mafirakureva N; Mukherjee S; de Souza M; Kelly-Cirino C; Songane MJP; Cohn J; Lemaire JF; Casenghi M; Dodd PJ
PLoS Med; 2023 Sep; 20(9):e1004285. PubMed ID: 37672524
[TBL] [Abstract][Full Text] [Related]
15. The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh.
Teerawattananon Y; Tantivess S; Yamabhai I; Tritasavit N; Walker DG; Cohen JT; Neumann PJ
Health Res Policy Syst; 2016 Dec; 14(1):86. PubMed ID: 27912780
[TBL] [Abstract][Full Text] [Related]
16. The costs of scaling up HIV and syphilis testing in low- and middle-income countries: a systematic review.
Adawiyah RA; Saweri OPM; Boettiger DC; Applegate TL; Probandari A; Guy R; Guinness L; Wiseman V
Health Policy Plan; 2021 Jun; 36(6):939-954. PubMed ID: 33693731
[TBL] [Abstract][Full Text] [Related]
17. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
Ekpu VU; Brown AK
Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
